Indy Star interviewed Thomas F. Imperiale, M.D., about his study published in the New England Journal of Medicine. This next generation multi-target stool DNA colorectal cancer screening test detects 94 percent of colorectal cancers and has the best performance for detection of both colorectal cancer and advanced precancerous polyps of any noninvasive colorectal cancer screening test.
-
Research
- Experts
In The News
View AllMedical Xpress features Dr. Joshua Vest and Dr. Chris Harle
Joshua Vest, Ph.D., and Christopher Harle, Ph.D., were featured by...
Influence
View AllCreating User Personas to Support Medication Management at Home
Understand the strategies and unmet needs of caregivers managing medications...
- Opportunities
Featured Fellowship
View all- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
- Experts
March 19, 2024
Indy Star interviewed Dr. Thomas F. Imperiale
